Literature DB >> 29476439

Sclerotherapy of peripheral low-flow vascular malformations: technical aspects and mid-term clinical outcome.

Francesco Giurazza1, Fabio Corvino2, Gianluca Cangiano2, Francesco Amodio2, Errico Cavaglià2, Mattia Silvestre2, Giuseppe De Magistris2, Salvatore Tecame2, Raffaella Niola2.   

Abstract

PURPOSE: The therapeutical management of low-flow vascular malformations (LFVMs) is challenging because of high recurrence rate; multiple strategies have been proposed. This paper aims to report a single-center experience of direct puncture sclerotherapy of peripheral LFVMs, focusing on technical aspects and clinical outcome in mid-term follow-up.
MATERIALS AND METHODS: 16 patients have been treated for peripheral LFVMs (mean age 36.1 years), complaining mild pain, swelling of the region of interest, and cosmetic nuisance. Preprocedural US and MR were acquired; angiography performed only in doubt vascular supply. Standard procedure consisted of direct puncture of the nidus using 20-23 gauge needles under US guidance and injection of up to 15 ml foam of sodium tetradecyl sulphate under fluoroscopic guidance. Clinical and radiological follow-up were assessed at 1, 3, and 6 months.
RESULTS: Lesions were localized: 8 in the upper and 5 the in lower limbs, 2 in the cheeks, and 1 in the vaginal labia. All procedures have been technically accomplished (100%). At 6 month follow-up, technical and clinical success were obtained in all cases, while radiological follow-up showed 81.2% (13 patients) complete vessels thrombosis after multiple sclerotherapy sessions. No major complications have been recorded; five patients (31.2%) referred minor complications.
CONCLUSIONS: Sclerotherapy via direct puncture of LFVMs is a clinically effective procedure, well tolerated by patients, with reduced costs and mild minor complications rate; interventionalists should always clarify to the patients that multiple sessions would be performed and recurrences are expected at imaging follow-up despite clinical improvement.

Entities:  

Keywords:  Direct puncture; Low flow; Peripheral; Sclerotherapy; Vascular malformation

Mesh:

Substances:

Year:  2018        PMID: 29476439     DOI: 10.1007/s11547-018-0869-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  16 in total

Review 1.  Percutaneous treatment of low flow vascular malformations.

Authors:  Patricia E Burrows; Keira P Mason
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

2.  Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System.

Authors:  D K Filippiadis; C Binkert; O Pellerin; R T Hoffmann; A Krajina; P L Pereira
Journal:  Cardiovasc Intervent Radiol       Date:  2017-06-05       Impact factor: 2.740

3.  Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.

Authors:  Mayank Goyal; Petrina A Causer; Derek Armstrong
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

Review 4.  Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck.

Authors:  John P Deveikis
Journal:  Arch Facial Plast Surg       Date:  2005 Sep-Oct

5.  Venous malformation: risk of progression during childhood and adolescence.

Authors:  Aladdin H Hassanein; John B Mulliken; Steven J Fishman; Ahmad I Alomari; David Zurakowski; Arin K Greene
Journal:  Ann Plast Surg       Date:  2012-02       Impact factor: 1.539

6.  Soft-tissue venous malformations in adult patients: imaging and therapeutic issues.

Authors:  J Dubois; G Soulez; V L Oliva; M J Berthiaume; C Lapierre; E Therasse
Journal:  Radiographics       Date:  2001 Nov-Dec       Impact factor: 5.333

Review 7.  Classification, diagnosis, and interventional radiologic management of vascular malformations.

Authors:  Gerald M Legiehn; Manraj K S Heran
Journal:  Orthop Clin North Am       Date:  2006-07       Impact factor: 2.472

8.  Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.

Authors:  Takashi Yamaki; Motohiro Nozaki; Hiyoyuki Sakurai; Masaki Takeuchi; Kazutaka Soejima; Taro Kono
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

Review 9.  Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review.

Authors:  Carine J M van der Vleuten; Anne Kater; Marc H W A Wijnen; Leo J Schultze Kool; Maroeska M Rovers
Journal:  Cardiovasc Intervent Radiol       Date:  2013-11-07       Impact factor: 2.740

Review 10.  Endovascular management of venous malformations.

Authors:  M Rosenblatt
Journal:  Phlebology       Date:  2007       Impact factor: 1.701

View more
  1 in total

1.  Transarterial embolization of peripheral high-flow arteriovenous malformation with ethylene vinyl alcohol copolymer (Onyx®): single-center 10-year experience.

Authors:  Francesco Giurazza; Fabio Corvino; Gianluca Cangiano; Errico Cavaglià; Francesco Amodio; Mattia Silvestre; Giuseppe De Magistris; Raffaella Niola
Journal:  Radiol Med       Date:  2018-10-27       Impact factor: 3.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.